blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2493873

EP2493873 - FLUORINATED 2,6-DIALKYL-3,5-DICYANO-4-(1H-INDAZOL-5-YL)-1,4-DIHYDROPYRIDINES AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.02.2015
Database last updated on 19.03.2026
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Bayer Intellectual Property GmbH
Alfred-Nobel-Strasse 10
40789 Monheim / DE
[2012/39]
Former [2012/36]For all designated states
Bayer Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
Inventor(s)01 / MICHELS, Martin
Am Klausenberg 55
51109 Köln / DE
02 / FOLLMANN, Markus
Ringstr. 61
42489 Wülfrath / DE
03 / VAKALOPOULOS, Alexandros
Heinrich-Heine-Str. 79a
40721 Hilden / DE
04 / ZIMMERMANN, Katja
Bockumerstr. 370
40489 Düsseldorf / DE
05 / TEUSCH, Nicole
Ringstr. 61
42489 Wülfrath / DE
06 / LOBELL, Mario
Am Eigenbach 16
42113 Wuppertal / DE
07 / ENGEL, Karen
Goethestr. 55
42327 Wuppertal / DE
 [2012/36]
Representative(s)BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 50
40789 Monheim am Rhein / DE
[N/P]
Former [2014/15]BIP Patents
c/o Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Former [N/P]BIP Patents
c/o Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
DE-40789 Monheim / DE
Former [2013/01]BIP Patents
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Former [2012/39]Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Former [2012/36](deleted)
Application number, filing date10759927.601.10.2010
WO2010EP64645
Priority number, dateEP2009017231006.10.2009         Original published format: EP 09172310
[2012/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011042367
Date:14.04.2011
Language:EN
[2011/15]
Type: A1 Application with search report 
No.:EP2493873
Date:05.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 14.04.2011 takes the place of the publication of the European patent application.
[2012/36]
Type: B1 Patent specification 
No.:EP2493873
Date:09.04.2014
Language:EN
[2014/15]
Search report(s)International search report - published on:EP14.04.2011
ClassificationIPC:C07D401/04, A61K31/4427
[2013/46]
CPC:
C07D401/04 (EP,US); A61K9/0019 (EP,US); A61K9/08 (EP,US);
A61K9/19 (EP,US); A61K9/2018 (EP,US); A61K9/2054 (EP,US);
A61K9/2059 (EP,US); A61K9/4858 (EP,US); A61K9/4866 (EP,US);
A61P35/00 (EP); A61P43/00 (EP) (-)
Former IPC [2012/36]C07D401/04, A61K31/416
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/36]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:FLUORIERTE 2,6-DIALKYL-3,5-DICYANO-4-(1H-INDAZOL-5-YL)-1,4-DIHYDROPYRIDINE UND VERWENDUNGSVERFAHREN DAFÜR[2012/36]
English:FLUORINATED 2,6-DIALKYL-3,5-DICYANO-4-(1H-INDAZOL-5-YL)-1,4-DIHYDROPYRIDINES AND METHODS OF USE THEREOF[2012/36]
French:2,6-DIALKYL-3,5-DICYANO-4-(1H-INDAZOL-5-YL)-1,4-DIHYDROPYRIDINES FLUORÉES ET LEURS PROCÉDÉS D'UTILISATION[2012/36]
Entry into regional phase07.05.2012National basic fee paid 
07.05.2012Designation fee(s) paid 
07.05.2012Examination fee paid 
Examination procedure07.05.2012Examination requested  [2012/36]
19.11.2012Amendment by applicant (claims and/or description)
30.10.2013Communication of intention to grant the patent
14.02.2014Fee for grant paid
14.02.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  30.10.2013
Opposition(s)12.01.2015No opposition filed within time limit [2015/12]
Fees paidRenewal fee
11.10.2012Renewal fee patent year 03
14.10.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.10.2010
AL09.04.2014
AT09.04.2014
BE09.04.2014
CY09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
MK09.04.2014
MT09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
SM09.04.2014
TR09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
[2018/46]
Former [2018/30]HU01.10.2010
AT09.04.2014
BE09.04.2014
CY09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
MK09.04.2014
MT09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
SM09.04.2014
TR09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2016/33]HU01.10.2010
AT09.04.2014
BE09.04.2014
CY09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
MT09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
SM09.04.2014
TR09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2016/32]HU01.10.2010
AT09.04.2014
BE09.04.2014
CY09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
SM09.04.2014
TR09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2016/31]AT09.04.2014
BE09.04.2014
CY09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
SM09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2016/22]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
SM09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2015/46]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
IE01.10.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2015/36]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SI09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2015/33]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
LU01.10.2014
CH31.10.2014
LI31.10.2014
Former [2015/27]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
MC09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
LU01.10.2014
Former [2015/26]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
LU01.10.2014
Former [2015/11]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
RO09.04.2014
RS09.04.2014
SE09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
Former [2015/10]AT09.04.2014
BE09.04.2014
CZ09.04.2014
DK09.04.2014
EE09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
RS09.04.2014
SE09.04.2014
SK09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
Former [2015/08]AT09.04.2014
BE09.04.2014
DK09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
RS09.04.2014
SE09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
Former [2015/02]AT09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
RS09.04.2014
SE09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
PT11.08.2014
Former [2014/52]AT09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
RS09.04.2014
SE09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
Former [2014/51]AT09.04.2014
FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
SE09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
Former [2014/50]FI09.04.2014
HR09.04.2014
LT09.04.2014
LV09.04.2014
NL09.04.2014
PL09.04.2014
SE09.04.2014
BG09.07.2014
NO09.07.2014
GR10.07.2014
IS09.08.2014
Former [2014/49]FI09.04.2014
LT09.04.2014
BG09.07.2014
NO09.07.2014
IS09.08.2014
Former [2014/48]LT09.04.2014
BG09.07.2014
Cited inby applicantWO2006066011
 WO2006074419
 WO2008071451
 WO2005085227
 US2005227968
 US3635977
 EP0379917
 EP0780408
   C.S. COOPER ET AL., NATURE, vol. 311, 1984, pages 29 - 33
   G.A. RODRIGUES ET AL., MOL. CELL BIOL., vol. 11, 1991, pages 2962 - 70
   C. PONZETTO ET AL., CELL, vol. 77, 1994, pages 261 - 71
   L. NALDINI ET AL., ONCOGENE, vol. 6, 1991, pages 501 - 4
   N. TOMITA ET AL., CIRCULATION, vol. 107, 2003, pages 1411 - 1417
   S. DING ET AL., BLOOD, vol. 101, 2003, pages 4816 - 4822
   Q. ZENG ET AL., J. BIOL. CHEM., vol. 277, 2002, pages 25203 - 25208
   N. HORIGUCHI ET AL., ONCOGENE, vol. 21, 2002, pages 1791 - 1799
   A. BARDELLI ET AL., EMBO J., vol. 15, 1996, pages 6205 - 6212
   P. LONGATI ET AL., CELL DEATH DIFFER., vol. 3, 1996, pages 23 - 28
   E.M. ROSEN, SYMP. SOC. EXP. BIOL., vol. 47, 1993, pages 227 - 234
   L. SCHMIDT ET AL., NAT. GENET, vol. 16, 1997, pages 68 - 73
   B. ZBAR ET AL., ADV. CANCER RES., vol. 75, 1998, pages 163 - 201
   M. KONG-BELTRAN ET AL., ANCER RES, vol. 66, 2006, pages 283 - 9
   T.E. TAHER ET AL., J. IMMUNOL., vol. 169, 2002, pages 3793 - 800
   P. PESCHARD ET AL., MOL. CELL, vol. 8, 2001, pages 995 - 1004
   J.A. ENGELMANN ET AL., SCIENCE, vol. 316, 2007, pages 1039 - 1043
   J.G. CHRISTENSEN ET AL., CANCER LETT., vol. 225, 2005, pages 1 - 26
   BIRCHMEIER ET AL., NAT. REV. MOL. CELL BIOL., vol. 4, 2003, pages 915 - 25
   J.J. CUI, EXPERT OPIN. THER. PATENTS, vol. 17, 2007, pages 1035 - 45
   S. M. BERGE ET AL.: "Pharmaceutical Salts", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19, XP002675560, DOI: doi:10.1002/jps.2600660104

DOI:   http://dx.doi.org/10.1002/jps.2600660104
   D.M. STOUT; A.I. MEYERS, CHEM. REV., vol. 82, 1982, pages 223 - 243
   H. MEIER ET AL., LIEBIGS ANN. CHEM., 1977, pages 1888
   F. BOSSERT ET AL., ANGEW. CHEM., vol. 93, 1981, pages 755
   C.G. KRESPAN, J. ORG. CHEM., vol. 34, 1969, pages 42
   ORG. REACT., vol. 15, 1967, pages 1
   B.A. CUNNINGHAM: "A Growing Issue: Cell Proliferation Assays. Modern kits ease quantification of cell growth", THE SCIENTIST, vol. 15, no. 13, 2001, pages 26
   S.P. CROUCH ET AL.: "The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 160, 1993, pages 81 - 88, XP023653002, DOI: doi:10.1016/0022-1759(93)90011-U

DOI:   http://dx.doi.org/10.1016/0022-1759(93)90011-U
   P. ARTURSSON; J. KARLSSON: "Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells", BIOCHEM. BIOPHYS., vol. 175, no. 3, 1991, pages 880 - 885, XP024770797, DOI: doi:10.1016/0006-291X(91)91647-U

DOI:   http://dx.doi.org/10.1016/0006-291X(91)91647-U
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.